Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Phillips

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Expert Opinion on Investigational Drugs|July 5, 2005
Prospects for bioreductive drug developmentR M Phillips
Biochemical Pharmacology|December 13, 1996
Bioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-beta-en-alpha-ol (EO9) by human DT-diaphoraseR M Phillips
Biochemical Pharmacology|July 28, 1999
Inhibition of DT-diaphorase (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug developmentR M Phillips
Journal of Oral Surgery (American Dental Association : 1965)|June 1, 1970
X-ray-induced changes in function and structure of the rat parotid glandR M Phillips
Journal of Perinatology : Official Journal of the California Perinatal Association|June 28, 2013
Multidisciplinary guidelines for the care of late preterm infants. IntroductionR M Phillips
The West Virginia Medical Journal|November 1, 1983
Career choices, accomplishments: women graduates of West Virginia University School of MedicineR M Phillips
Expert Opinion on Investigational Drugs|February 24, 2001
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsR M Phillips
Journal of Oral Surgery (American Dental Association : 1965)|November 1, 1970
Early management of maxillofacial war injuriesR M Phillips
Methods in Molecular Medicine|February 23, 2011
Hollow fiber assay for tumor angiogenesisR M Phillips, M C Bibby
Postgraduate Medicine|September 1, 1981
Scleroderma. Current understanding of pathogenesis and managementR M Phillips, C K Wasner
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Expert Opinion on Investigational Drugs|July 5, 2005
Prospects for bioreductive drug developmentR M Phillips
Biochemical Pharmacology|December 13, 1996
Bioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-beta-en-alpha-ol (EO9) by human DT-diaphoraseR M Phillips
Biochemical Pharmacology|July 28, 1999
Inhibition of DT-diaphorase (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug developmentR M Phillips
Journal of Oral Surgery (American Dental Association : 1965)|June 1, 1970
X-ray-induced changes in function and structure of the rat parotid glandR M Phillips
Journal of Perinatology : Official Journal of the California Perinatal Association|June 28, 2013
Multidisciplinary guidelines for the care of late preterm infants. IntroductionR M Phillips
The West Virginia Medical Journal|November 1, 1983
Career choices, accomplishments: women graduates of West Virginia University School of MedicineR M Phillips
Expert Opinion on Investigational Drugs|February 24, 2001
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsR M Phillips
Journal of Oral Surgery (American Dental Association : 1965)|November 1, 1970
Early management of maxillofacial war injuriesR M Phillips
Methods in Molecular Medicine|February 23, 2011
Hollow fiber assay for tumor angiogenesisR M Phillips, M C Bibby
Postgraduate Medicine|September 1, 1981
Scleroderma. Current understanding of pathogenesis and managementR M Phillips, C K Wasner
Pageof 11